Futura Medical plc (FUM.L) LSE

2.76

+0.259(+10.36%)

Updated at October 21 10:25AM

Currency In GBp

Futura Medical plc

Address

Surrey Technology Centre

Guildford, GU2 7YG

United Kingdom of Great Britain and Northern Ireland

Phone

44 14 8368 5670

Sector

Healthcare

Industry

Biotechnology

Employees

14

First IPO Date

July 22, 2003

Key Executives

NameTitlePayYear Born
Mr. James Henry BarderChief Executive Officer & Executive Director469,5541959
Mr. Kenneth William JamesHead of R&D & Executive Director344,0001952
Ms. Angela HildrethChief Operating Officer, Finance Director, Company Secretary & Executive Director374,7851980
Graham SmithHead of Alliance Partnerships & Supply0N/A
Dr. William Duncan PotterChief Scientific Officer & Adviser to the Board01948
Kevin LangridgeHead of Quality0N/A

Description

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.